Yingpeng Xie

Yingpeng Xie

Auto-generated profile, based on publicly available information

Yingpeng Xie

Department of Biomedical Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong SAR, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
HHHao Huang
Hao Huang
XSXiaolong Shao
Xiaolong Shao
YXYingpeng Xie
Yingpeng Xie
TWTingting Wang
Tingting Wang
YZYingchao Zhang
Yingchao Zhang
XDXin Deng
Xin Deng
The virulence of Pseudomonas aeruginosa, a Gram-negative opportunistic pathogen, is regulated by many transcriptional factors (TFs) that control the expression of quorum sensing and protein secretion systems. Here, we report a genome-wide, network-based approach to dissect the crosstalk between 20 key virulence-related TFs. Using chromatin immunoprecipitation coupled with high-throughput sequencing (ChIP-seq), as well as RNA-seq, we identify 1200 TF-bound genes and 4775 differentially expressed genes. We experimentally validate 347 of these genes as functional target genes, and describe the regulatory relationships of the 20 TFs with their targets in a network that we call ‘Pseudomonas aeruginosa genomic regulatory network’ (PAGnet). Analysis of the network led to the identification of novel functions for two TFs (ExsA and GacA) in quorum sensing and nitrogen metabolism. Furthermore, we present an online platform and R package based on PAGnet to facilitate updating and user-customised analyses.

15 August 2018 in Journal of Bacteriology
Verified
Journal Article
Closed access
PDF file
XSXiaolong Shao
Xiaolong Shao
XZXiaoning Zhang
Xiaoning Zhang
YZYingchao Zhang
Yingchao Zhang
MZMiao Zhu
Miao Zhu
PYPan Yang
Pan Yang
XDXin Deng
Xin Deng
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen of humans, particularly those with cystic fibrosis. As a global regulator, RpoN controls a group of virulence-related factors and quorum-sensing (QS) genes in P. aeruginosa. To gain further insights into the direct targets of RpoN in vivo, the present study focused on identifying the direct targets of RpoN regulation in QS and the type VI secretion system (T6SS). We performed chromatin immunoprecipitation coupled with high-throughput sequencing (ChIP-seq) that identified 1,068 binding sites of RpoN, mostly including metabolic genes, a group of genes in QS (lasI, rhlI, and pqsR) and the T6SS (hcpA and hcpB). The direct targets of RpoN have been verified by electrophoretic mobility shifts assays (EMSA), lux reporter assay, reverse transcription-quantitative PCR, and phenotypic detection. The ΔrpoN::Tc mutant resulted in the reduced production of pyocyanin, motility, and proteolytic activity. However, the production of rhamnolipids and biofilm formation were higher in the ΔrpoN::Tc mutant than in the wild type. In summary, the results indicated that RpoN had direct and profound effects on QS and the T6SS. IMPORTANCE As a global regulator, RpoN controls a wide range of biological pathways, including virulence in P. aeruginosa PAO1. This work shows that RpoN plays critical and global roles in the regulation of bacterial pathogenicity and fitness. ChIP-seq provided a useful database to characterize additional functions and targets of RpoN in the future. The functional characterization of RpoN-mediated regulation will improve the current understanding of the regulatory network of quorum sensing and virulence in P. aeruginosa and other bacteria.

25 February 2020 in mBio
Verified
Journal Article
Open access
PDF file
XSXiaolong Shao
Xiaolong Shao
WZWeitong Zhang
Weitong Zhang
MUMubarak Ishaq Umar
Mubarak Ishaq Umar
HWHei Yuen Wong
Hei Yuen Wong
ZSZijing Seng
Zijing Seng
XDXin Deng
Xin Deng
G-quadruplex in RNA (rG4) mediates various biological functions and cellular processes in eukaryotic organisms. However, the presence, locations, and functions of rG4 are still elusive in prokaryotes. Here, we found that rG4 is an abundant RNA secondary structure across a wide range of bacterial species. Subsequently, the transcriptome-wide rG4 structure sequencing (rG4-seq) revealed that the model E. coli strain and a major human pathogen, P. aeruginosa , have 168 and 161 in vitro rG4 sites, respectively, involved in virulence, gene regulation, cell envelope, and metabolism. We further verified the regulatory functions of two rG4 sites in bacteria ( hemL and bswR ). Overall, this finding strongly suggests that rG4s play key regulatory roles in a wide range of bacterial species.

27 August 2019 in Environmental Microbiology
Verified
Journal Article
Closed access
YXYingpeng Xie
Yingpeng Xie
XSXiaolong Shao
Xiaolong Shao
XDXin Deng
Xin Deng

24 February 2020 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
GCGukui Chen
Gukui Chen
JGJianhua Gan
Jianhua Gan
CYChun Yang
Chun Yang
YZYili Zuo
Yili Zuo
JPJuan Peng
Juan Peng
Haihua LiangHaihua Liang
Haihua Liang
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

15 May 2019 in Applied and Environmental Microbiology
Verified
Journal Article
Open access
PDF file
Tingting WangTingting Wang
Tingting Wang
ZCZhao Cai
Zhao Cai
XSXiaolong Shao
Xiaolong Shao
WZWeitong Zhang
Weitong Zhang
YXYingpeng Xie
Yingpeng Xie
XDXin Deng
Xin Deng
The present work comprehensively analyzed the transcriptome and phenotypes that were regulated by c-di-GMP in P. syringae . Given that the majority of diguanylate cyclases and phosphodiesterases have not been characterized in P. syringae , this work provided a very useful database for the future study on regulatory mechanism (especially its relationship with T3SS) of c-di-GMP in P. syringae . In particular, we identified three promoters that were sensitive to elevated c-di-GMP levels and inserted them into luciferase-based reporters that effectively respond to intracellular levels of c-di-GMP in P. syringae , which could be used as an economic and efficient way to measure relative c-di-GMP levels in vivo in the future.